Zhong Guo Jing Ji Wang·2025-09-15 08:08Core Insights - The company JinDike (688670.SH) reported a revenue of 3.524 million yuan for the first half of 2025, representing a year-on-year increase of 7.18% [1][2] - The net profit attributable to the parent company was -39.653 million yuan, with a net profit excluding non-recurring items of -42.941 million yuan [1][2] - The net cash flow from operating activities was -85.488 million yuan [1][2] Financial Performance - For the first half of 2025, the company achieved a revenue of 3,524,238.84 yuan, up from 3,288,169.37 yuan in the same period last year, marking a 7.18% increase [2] - The net profit attributable to shareholders was -39,653,098.13 yuan, slightly improved from -40,867,089.23 yuan year-on-year [2] - The net profit after excluding non-recurring items was -42,940,823.45 yuan, compared to -47,145,812.18 yuan in the previous year [2] - The net cash flow from operating activities was -85,488,113.52 yuan, an improvement from -89,270,106.59 yuan in the same period last year [2] Yearly Comparison - In 2024, the company reported a revenue of 80.802 million yuan, a significant decrease of 39.96% compared to 134.591 million yuan in 2023 [3] - The net profit attributable to shareholders for 2024 was -93.502 million yuan, worsening from -70.990 million yuan in 2023 [3] - The net profit excluding non-recurring items was -106.224 million yuan, compared to -72.571 million yuan in the previous year [3] IPO and Fundraising - JinDike raised a total of 1.214 billion yuan from its initial public offering, with a net amount of 1.136 billion yuan, which was 464 million yuan less than initially planned [4] - The funds were intended for the construction of a new vaccine production facility, vaccine research and development, working capital, and repayment of bank loans [4] - The underwriting fees for the IPO totaled 78.2839 million yuan, with CITIC Securities receiving 64.3399 million yuan [4]